⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MTVA News
MetaVia Inc. Common Stock
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
globenewswire.com
JUNS
DYAI
PHIO
CVKD
TNXP
MTVA
XAIR
AEMD
NSRX
ICU
JAGX
MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035
prnewswire.com
MTVA
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
prnewswire.com
MTVA
Presenting on Emerging Growth Conference 90 Day 2 on February 26; Register to live stream
globenewswire.com
CRGO
OESX
CLNN
UMAC
AEMD
MTVA
ASPI
USAU
ZENA
USEG
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
globenewswire.com
CRGO
OESX
UMAC
CLNN
MTVA
ASPI
AEMD
ZENA
USEG
USAU
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference
prnewswire.com
MTVA
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041
prnewswire.com
MTVA
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel
prnewswire.com
MTVA
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option
prnewswire.com
MTVA
MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering
prnewswire.com
MTVA